Accordingly, the myeloid cell's Trim24 deficiency impaired the tumor infiltration of IFNγ-producing CD4+ and CD8+ effector T cells (Fig. 7l), suggesting that Trim24 deficiency impaired antitumor immunity through suppressed Stat6 acetylation in TAMs. Here, STAT6 is linked to neoplasm.